Here's why Transurban Group is a rock-solid investment for turbulent times

Transurban Group (ASX:TCL) would appear to offer investors a reliable stream of dividends backed by hard, monopolistic assets.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

What: Leading toll road operator Transurban Group (ASX: TCL) has announced that on 29 December it expects to begin tolling on its 77.5% owned toll way, the 95 Express Lanes, in Northern Virginia, USA.

So What: A new revenue stream for the group is good news for shareholders. While Transurban already owns a spread of assets across Australia – including Melbourne's CityLink, numerous roads in Sydney including the Lane Cove Tunnel, Cross City Tunnel, Hills M2 Motorway and the Eastern Distributor and Brisbane's CLEM7 (amongst others) – this is just its second overseas assets. The 95 adds to the group's 94% shareholding in the 495 Express Lanes, which is also located in the state of Virginia, USA.

Investment bank Merill Lynch appears to be positive on Transurban's outlook with The Australian Financial Review reporting that the broker rates the stock as a "buy" with a price target of $9.15. That compares favourably with the current share price of $8.69.

What now: There are relatively few infrastructure asset plays available to ASX investors. Amongst the other options are Macquarie Atlas Roads Limited (ASX: MQA), which also owns toll roads in the USA and Sydney Airport Limited (ASX: SYD), which is a single asset business. In all cases one of the most difficult elements for investors is understanding the financing arrangements of these highly leveraged assets.

With investors deserting many stocks, particularly those exposed to oil and gas, the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) is struggling to hold its ground. This is one of the benefits of owning a regulated infrastructure asset such as Transurban – there is a steady and reliable cash flow backed by hard, monopolistic assets.

Based on analyst consensus data provided by Morningstar, earnings per share for the group are expected to rise from 24.6 cents per share (cps) in FY 2015 to 52.3 cps in FY 2017. These gains are expected to support a rise in the dividend from a forecast 39 cps in FY 2015 to 48 cps in FY 2017.

Motley Fool contributor Tim McArthur does not own shares in any of the companies mentioned in this article.  

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »